167 related articles for article (PubMed ID: 21325104)
21. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue.
Telejko B; Kuzmicki M; Zonenberg A; Szamatowicz J; Wawrusiewicz-Kurylonek N; Nikolajuk A; Kretowski A; Gorska M
Diabetes Res Clin Pract; 2009 Apr; 84(1):68-75. PubMed ID: 19185944
[TBL] [Abstract][Full Text] [Related]
22. First-Trimester Maternal Serum Amino Acids and Acylcarnitines Are Significant Predictors of Gestational Diabetes.
Nevalainen J; Sairanen M; Appelblom H; Gissler M; Timonen S; Ryynänen M
Rev Diabet Stud; 2016; 13(4):236-245. PubMed ID: 28278310
[TBL] [Abstract][Full Text] [Related]
23. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus.
Tsiotra PC; Halvatsiotis P; Patsouras K; Maratou E; Salamalekis G; Raptis SA; Dimitriadis G; Boutati E
Peptides; 2018 Mar; 101():157-166. PubMed ID: 29337272
[TBL] [Abstract][Full Text] [Related]
24. Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes.
Rasanen JP; Snyder CK; Rao PV; Mihalache R; Heinonen S; Gravett MG; Roberts CT; Nagalla SR
Obstet Gynecol; 2013 Sep; 122(3):586-94. PubMed ID: 23921871
[TBL] [Abstract][Full Text] [Related]
25. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.
Lewandowski KC; Stojanovic N; Press M; Tuck SM; Szosland K; Bienkiewicz M; Vatish M; Lewinski A; Prelevic GM; Randeva HS
Diabetologia; 2007 May; 50(5):1033-7. PubMed ID: 17334748
[TBL] [Abstract][Full Text] [Related]
27. Circulating visfatin levels in the second and third trimester of pregnancies with gestational diabetes: a systematic review.
Pace NP; Bonello A; Roshan MH; Vassallo J
Minerva Ginecol; 2019 Aug; 71(4):329-343. PubMed ID: 31274262
[TBL] [Abstract][Full Text] [Related]
28. Maternal Diabetes, Large-for-Gestational-Age Births, and First Trimester Pregnancy-Associated Plasma Protein-A.
Wells G; Bleicher K; Han X; McShane M; Chan YF; Bartlett A; White C; Lau SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):2372-9. PubMed ID: 25825946
[TBL] [Abstract][Full Text] [Related]
29. Plasma visfatin levels in pregnant women with normal glucose tolerance, gestational diabetes and pre-gestational diabetes mellitus.
Coskun A; Ozkaya M; Kiran G; Kilinc M; Arikan DC
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1014-8. PubMed ID: 20059442
[TBL] [Abstract][Full Text] [Related]
30. Impact of maternal serum levels of Visfatin, AFP, PAPP-A, sFlt-1 and PlGF at 11-13 weeks gestation on small for gestational age births.
Birdir C; Fryze J; Frölich S; Schmidt M; Köninger A; Kimmig R; Schmidt B; Gellhaus A
J Matern Fetal Neonatal Med; 2017 Mar; 30(6):629-634. PubMed ID: 27124371
[TBL] [Abstract][Full Text] [Related]
31. Maternal hemodynamics at 11-13 weeks' gestation in gestational diabetes mellitus.
Khalil A; Garcia-Mandujano R; Chiriac R; Akolekar R; Nicolaides KH
Fetal Diagn Ther; 2012; 31(4):216-20. PubMed ID: 22572717
[TBL] [Abstract][Full Text] [Related]
32. Increased Maternal Serum Interleukin-6 Concentrations at 11 to 14 Weeks of Gestation in Low Risk Pregnancies Complicated with Gestational Diabetes Mellitus: Development of a Prediction Model.
Hassiakos D; Eleftheriades M; Papastefanou I; Lambrinoudaki I; Kappou D; Lavranos D; Akalestos A; Aravantinos L; Pervanidou P; Chrousos G
Horm Metab Res; 2016 Jan; 48(1):35-41. PubMed ID: 25565094
[TBL] [Abstract][Full Text] [Related]
33. Adipokines and β-cell dysfunction in normoglycemic women with previous gestational diabetes mellitus.
Molęda P; Fronczyk A; Safranow K; Majkowska L
Pol Arch Med Wewn; 2015; 125(9):641-8. PubMed ID: 26252176
[TBL] [Abstract][Full Text] [Related]
34. Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study.
Thagaard IN; Krebs L; Holm JC; Lange T; Larsen T; Christiansen M
Clin Chem Lab Med; 2017 Oct; 55(11):1805-1812. PubMed ID: 28763297
[TBL] [Abstract][Full Text] [Related]
35. Glycosylated fibronectin as a first trimester marker for gestational diabetes.
Alanen J; Appelblom H; Korpimaki T; Kouru H; Sairanen M; Gissler M; Ryynanen M; Nevalainen J
Arch Gynecol Obstet; 2020 Oct; 302(4):853-860. PubMed ID: 32653948
[TBL] [Abstract][Full Text] [Related]
36. A Novel Early Pregnancy Risk Prediction Model for Gestational Diabetes Mellitus.
Sweeting AN; Wong J; Appelblom H; Ross GP; Kouru H; Williams PF; Sairanen M; Hyett JA
Fetal Diagn Ther; 2019; 45(2):76-84. PubMed ID: 29898442
[TBL] [Abstract][Full Text] [Related]
37. First trimester serum biomarkers to predict gestational diabetes in a high-risk cohort: Striving for clinically useful thresholds.
Corcoran SM; Achamallah N; Loughlin JO; Stafford P; Dicker P; Malone FD; Breathnach F
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():7-12. PubMed ID: 29328940
[TBL] [Abstract][Full Text] [Related]
38. Maternal Subcutaneous and Visceral Adipose Ultrasound Thickness in Women with Gestational Diabetes Mellitus at 24-28 Weeks' Gestation.
D'Ambrosi F; Crovetto F; Colosi E; Fabietti I; Carbone F; Tassis B; Motta S; Bulfoni A; Fedele L; Rossi G; Persico N
Fetal Diagn Ther; 2018; 43(2):143-147. PubMed ID: 28624818
[TBL] [Abstract][Full Text] [Related]
39. A First-Trimester Biomarker Panel for Predicting the Development of Gestational Diabetes.
Farina A; Eklund E; Bernabini D; Paladino M; Righetti F; Monti G; Lambert-Messerlian G
Reprod Sci; 2017 Jun; 24(6):954-959. PubMed ID: 27837083
[TBL] [Abstract][Full Text] [Related]
40. Role of serum biomarkers to optimise a validated clinical risk prediction tool for gestational diabetes.
Abell SK; Shorakae S; Boyle JA; De Courten B; Stepto NK; Teede HJ; Harrison CL
Aust N Z J Obstet Gynaecol; 2019 Apr; 59(2):251-257. PubMed ID: 29900538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
